Pilot study of 5-hour molecular test accurately distinguishes malignant and benign breast tumors

by Johns Hopkins University School of MedicineInvestigator Bradley Downs assembling cartridge assay that distinguishes cancer from benign aspirates from mammographically suspicious breast lesions

Updated on: March 14,2024 17

Pilot study of 5-hour molecular test accurately distinguishes malignant and benign breast tumors

by Johns Hopkins University School of MedicineInvestigator Bradley Downs assembling cartridge assay that distinguishes cancer from benign aspirates from mammographically suspicious breast lesions

Updated on:March 14,2024 17

Drug-pricing program improves prostate cancer treatment adherence, finds study

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainProstate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to

Updated on: March 30,2024 0

Drug-pricing program improves prostate cancer treatment adherence, finds study

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainProstate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to

Updated on:March 30,2024 0

Immunotherapy for blood cancer: Remote destruction of tumor cells demonstrated

byPasteur InstituteGating strategies for flow cytometry identification of pro-B-cell tumors. (a) Gating strategy for identifying pro-B-cell tumors expressing the FRET-based caspase 3 reporter (n

Updated on: January 15,2024 17

Immunotherapy for blood cancer: Remote destruction of tumor cells demonstrated

byPasteur InstituteGating strategies for flow cytometry identification of pro-B-cell tumors. (a) Gating strategy for identifying pro-B-cell tumors expressing the FRET-based caspase 3 reporter (n

Updated on:January 15,2024 17

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh

Updated on: January 07,2024 9

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh

Updated on:January 07,2024 9

Study: Vaccine helps drug keep melanoma patients cancer-free

by Angelica PeeblesCredit: Unsplash/CC0 Public DomainAdding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-de

Updated on: February 03,2024 15

Study: Vaccine helps drug keep melanoma patients cancer-free

by Angelica PeeblesCredit: Unsplash/CC0 Public DomainAdding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-de

Updated on:February 03,2024 15

Researchers find a new promising therapeutic target for glioblastoma

by Spanish National Research CouncilGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Glioblastoma is the most frequent and aggre

Updated on: June 19,2024 7

Researchers find a new promising therapeutic target for glioblastoma

by Spanish National Research CouncilGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Glioblastoma is the most frequent and aggre

Updated on:June 19,2024 7

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on: January 08,2024 10

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on:January 08,2024 10

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on: April 01,2024 18

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on:April 01,2024 18

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre

Updated on: January 30,2024 19

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre

Updated on:January 30,2024 19

Young cancer survivors in Europe get increased post-cure help

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageAs medical advances in oncology enable more patients to beat tumors, greater attention is being paid t

Updated on: February 03,2024 14

Young cancer survivors in Europe get increased post-cure help

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageAs medical advances in oncology enable more patients to beat tumors, greater attention is being paid t

Updated on:February 03,2024 14

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl

Updated on: January 29,2024 20

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl

Updated on:January 29,2024 20

Study: More paid sick leave results in more cancer screenings

by Tulane UniversityCredit: Unsplash/CC0 Public DomainFor most Americans, the two major obstacles to proper medical care are time and money. And while insurance can sometimes reduce health care c

Updated on: February 18,2024 14

Study: More paid sick leave results in more cancer screenings

by Tulane UniversityCredit: Unsplash/CC0 Public DomainFor most Americans, the two major obstacles to proper medical care are time and money. And while insurance can sometimes reduce health care c

Updated on:February 18,2024 14